RIVRESSO Trademark

Trademark Overview

On Monday, September 19, 2016, a trademark application was filed for RIVRESSO with the United States Patent and Trademark Office. The USPTO has given the RIVRESSO trademark a serial number of 87175664. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by Pfizer Inc.. The RIVRESSO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of vaso-occlusive crisis (VOC); pharmaceutical preparations for the treatment of sickle cell disease
rivresso

General Information

Serial Number87175664
Word MarkRIVRESSO
Filing DateMonday, September 19, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of vaso-occlusive crisis (VOC); pharmaceutical preparations for the treatment of sickle cell disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 23, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, September 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 26, 2019EXTENSION 5 GRANTED
Monday, September 23, 2019EXTENSION 5 FILED
Thursday, September 26, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 23, 2019TEAS EXTENSION RECEIVED
Tuesday, September 10, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 8, 2019EXTENSION 4 GRANTED
Friday, March 8, 2019EXTENSION 4 FILED
Friday, March 8, 2019TEAS EXTENSION RECEIVED
Wednesday, September 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 17, 2018EXTENSION 3 GRANTED
Monday, September 17, 2018EXTENSION 3 FILED
Monday, September 17, 2018TEAS EXTENSION RECEIVED
Thursday, March 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 20, 2018EXTENSION 2 GRANTED
Tuesday, March 20, 2018EXTENSION 2 FILED
Tuesday, March 20, 2018TEAS EXTENSION RECEIVED
Saturday, September 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 7, 2017EXTENSION 1 GRANTED
Thursday, September 7, 2017EXTENSION 1 FILED
Thursday, September 7, 2017TEAS EXTENSION RECEIVED
Tuesday, April 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 24, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 23, 2016ASSIGNED TO EXAMINER
Friday, September 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 22, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

rivresso pharmaceutical treatment preparations cell disease sickle occlusive vaso crisis